CCR5 and metastatic malignant neoplasm in the lymph nodes: In the tumor tissue lysate, this trend was more obvious: the Treg/CCR5 ratio in the lymph node metastasis group and nonmetastasis group was 0.097 ± 0.148 and 0.079 ± 0.112, respectively, P < 0.001(Figure 8E).